Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2)

OBJECTIVES: Data on the immune response after two doses of BNT162b2 are so far limited. Previously infected individuals were excluded from pivotal clinical trials and the optimum dose regimen in this population has not been clearly studied. The CRO-VAX HCP study aims to investigate the early antibod...

Descripción completa

Detalles Bibliográficos
Autores principales: Favresse, Julien, Bayart, Jean-Louis, Mullier, François, Dogné, Jean-Michel, Closset, Mélanie, Douxfils, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106520/
https://www.ncbi.nlm.nih.gov/pubmed/33975007
http://dx.doi.org/10.1016/j.cmi.2021.05.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106520/
https://www.ncbi.nlm.nih.gov/pubmed/33975007
http://dx.doi.org/10.1016/j.cmi.2021.05.004

Ejemplares similares